chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For the subject of this study, Takeda Hospital respiratory organs physician and this study medical attendant perform confirmation, the medical examination of the anamnesis. Among patients meeting COPD diagnosis and guidelines diagnostic criteria of the guidelines fourth edition from the fourth edition editing Japan respiratory organs society COPD guidelines making Committeefor treatment, the purpose of this study is understood and intends for the patient of the chronic obstructive pulmonary disease to have a poor intractable disease in the effectiveness by the existing cure that obtained its consent in a document. Age, the sex do not matter. 1 The target disease patient who was admitted to the Takeda Hospital in an operation and treatment, an inspection purpose 2 The target disease patient who visits a hospital for treatment in the outpatient department of the Takeda Hospital 3 The patient who acquired an agreement of this study entry by the free will of the person in a document
Exclusion criteria
Exclusion criteria: The patient corresponding to the following standards excludes it from a patient targeted for the final examination. 1 The person that quantity of fat necessary for this study is not provided 2 The patient whom I am dialyzing 3 Pregnant patient 4 This study medical attendant is the patient who ethical, it is scientific, and made a decision from the viewpoint of safety if the participation in this study is inappropriate of the subject 5 The patient who needs Agent approval I confirm an anamnesis to advocate next and, from having experience or not that underwent a blood transfusion or transplant, do a competent thing judging. But I decide to reconfirm when I become able to confirm it about the anamnesis which I was not able to confirm at the time of a competent judgment later. 1 Infection with bacteria such as Treponema pallidum, a gonococcus, the tubercle bacillus 2 Sepsis and the doubt 3 Malignant tumor 4 Serious metabolism internal secretion disease 5 Serious blood disorder 6 Liver disease 7 Communicable spongy brain fever and the doubt 8 Family career to be concerned with a specific hereditary disease and the disease concerned 9 Pulmonary embolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| I evaluate the change of a symptom and the pulmonary function.Pulmonary function (the lung capacity, one second quantity), dyspnea (modified MRC), QOL, the hatred number of times, theweight, chest CT scanner, LAA %, nourishment evaluation | — |
Countries
Japan
Contacts
Takeda Hospital group headquarters Director of medical management